The Point-Of-Care Molecular Diagnostics Market is predicted to secure a valuation of US$ 4.4 billion in 2023 and is rising to US$ 11.1 billion by 2033. The market is estimated at a CAGR of 9.7% during the forecast period. Rising infectious and chronic diseases, such as cardiovascular, diabetes, and COVID-19, are increasing the adoption of point-of-care molecular diagnostics. …
Tag Archives: Point-of-care Molecular Diagnostics Market
Point-Of-Care Molecular Diagnostics Market is expected to reach US$ 11 Billion by 2032
The global point-of-care molecular diagnostics market was estimated to be worth US$ 3 billion in 2021 and is expected to grow at a robust CAGR of 8% between 2022 and 2032, reaching around US$ 11 billion by 2032. The rising prevalence of infectious diseases and cancer worldwide, as well as growing end user preference for …